Trial intelligence / Profile preview

Double blind randomized controlled trial of Levosimendan versus Dopexamine in septic shock

2004-004384-29Phase 4Completed

Sponsor
Aintree University Hospital
Start
Feb 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in septic shock comparing Levosimendan arm with Dopexamine arm (2 arms). Primary endpoints: Preservation of splanchnic blood flow and Hemodynamic and cardiac parameters. Started Feb 2005; status: completed.

02

Drugs

levosimendandopexamine
03

Conditions

septic shock

Beyond the preview

Go deeper on 2004-004384-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-004384-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call